CULLINAN ONCOLOGY LLC

NASDAQ: CGEM (Cullinan Therapeutics, Inc.)

Last update: 09 Sep, 2:34PM

18.14

0.16 (0.89%)

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bearish
Biotechnology (Global) Mixed Bearish
Stock Cullinan Therapeutics, Inc. Bullish Bearish

Stockmoo Score

-0.9

Similar Stocks

Stock Market Cap DY P/E P/B
CGEM 1 B - - 1.58
RVMD 7 B - - 4.47
IONS 7 B - - 22.54
LGND 2 B - 43.88 2.45
LQDA 826 M - - 12.18
CDMO 720 M - - 12.28

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

Sector Healthcare
Industry Biotechnology
Investment Style Small Core
52 Weeks Range
7.64 (-57%) — 30.19 (66%)
Price Target Range
28.00 (54%) — 36.00 (98%)
High 36.00 (Wedbush, 98.46%) Buy
Median 32.00 (76.41%)
Low 28.00 (HC Wainwright & Co., 54.36%) Buy
Average 32.00 (76.41%)
Total 2 Buy
Avg. Price @ Call 17.95
Firm Date Target Price Call Price @ Call
Wedbush 18 Sep 2024 36.00 (98.46%) Buy 17.95
09 Aug 2024 36.00 (98.46%) Buy 16.77
HC Wainwright & Co. 17 Sep 2024 28.00 (54.36%) Buy 17.95
16 Sep 2024 28.00 (54.36%) Buy 17.95
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
MICHAELSON JENNIFER - 17.93 -8,000 -143,440
Aggregate Net Quantity -8,000
Aggregate Net Value ($) -143,440
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 17.93
Name Holder Date Type Quantity Price Value ($)
MICHAELSON JENNIFER Officer 05 Sep 2024 Automatic sell (-) 8,000 17.93 143,440

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria